Drug:
Reaction: PNEUMONIA
20250101 - 20251231
No. 1001 - 1100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1001 | 25074691 |
66 | 2 | |
Pneumonia, Therapy interrupted, |
||||
AVACOPAN, AVACOPAN, |
||||
| 1002 | 25074749 |
US |
40 | 1 |
Pneumonia, Influenza, Blood glucose increased, Incorrect product administration duration, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 1003 | 25074783 |
US |
2 | |
Pneumonia, Influenza, Ear infection, Urinary tract infection, |
||||
CLADRIBINE, CLADRIBINE, |
||||
| 1004 | 25074805 |
US |
67 | 1 |
Pneumonia, Influenza, Dysphagia, Product use in unapproved indication, |
||||
BELUMOSUDIL, BELUMOSUDIL, RUXOLITINIB, |
||||
| 1005 | 25074834 |
CA |
65 | 2 |
Wheezing, Asthma, Drug hypersensitivity, Vomiting, Oedema, Dyspnoea, Pneumonia, |
||||
AMLODIPINE, AMINOPHYLLINE, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, CLONAZEPAM, ROSUVASTATIN, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, PREDNISOLONE SODIUM PHOSPHATE, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, MONTELUKAST SODIUM, TRAMADOL HYDROCHLORIDE, |
||||
| 1006 | 25074891 |
US |
76 | 2 |
Pneumonia, Sinusitis, Infection, Influenza, Joint swelling, |
||||
CLADRIBINE, |
||||
| 1007 | 25074952 |
CA |
57 | 2 |
Cough, Pneumonia, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 1008 | 25075047 |
US |
2 | |
Pneumonia, |
||||
TROFINETIDE, |
||||
| 1009 | 25075094 |
US |
||
Pneumonia, |
||||
PIRTOBRUTINIB, |
||||
| 1010 | 25075104 |
US |
81 | 2 |
Pneumonia, Influenza, Malaise, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, AZATHIOPRINE, |
||||
| 1011 | 25075139 |
US |
75 | 1 |
COVID-19, Pneumonia, |
||||
PACRITINIB, CALCIUM CARBONATE, ANTACID, BISACODYL, MAGNESIUM HYDROXIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, GABAPENTIN, GLIPIZIDE, ERGOCALCIFEROL, RUXOLITINIB, LISINOPRIL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 1012 | 25075177 |
US |
||
Pneumonia, Brain fog, Off label use, |
||||
RUXOLITINIB, RUXOLITINIB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METOPROLOL TARTRATE, METOPROLOL, LOSARTAN, ACYCLOVIR, PREDNISONE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 1013 | 25075196 |
BR |
||
Respiratory failure, Pneumonia, Asthma, Herpes zoster, |
||||
MEPOLIZUMAB, |
||||
| 1014 | 25075217 |
US |
1 | |
Pneumonia, Dyspnoea, |
||||
VOCLOSPORIN, |
||||
| 1015 | 25075225 |
US |
||
Pneumonia, |
||||
PATISIRAN, |
||||
| 1016 | 25075283 |
US |
64 | 2 |
Pneumonia, |
||||
DUPILUMAB, |
||||
| 1017 | 25075285 |
US |
1 | |
Pneumonia, |
||||
DUPILUMAB, PREDNISONE, ADALIMUMAB, ESCITALOPRAM OXALATE, ESCITALOPRAM, HYDROCHLOROTHIAZIDE, FUROSEMIDE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, BUDESONIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MONTELUKAST SODIUM, MONTELUKAST, ITRACONAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, |
||||
| 1018 | 25075609 |
US |
65 | 2 |
Cataract, Pneumonia, COVID-19, Memory impairment, Illness, |
||||
TOFACITINIB, |
||||
| 1019 | 25075701 |
CA |
60 | 2 |
Arthralgia, Asthenia, Burning sensation, COVID-19, Cold sweat, Immunodeficiency, Joint swelling, Productive cough, White blood cell count increased, Lower respiratory tract infection, Nasopharyngitis, Pneumonia, Weight increased, Bronchitis, Headache, Hot flush, Hypertension, Drug ineffective, Intentional dose omission, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, FOLIC ACID, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, METHOTREXATE, METHOTREXATE SODIUM, RABEPRAZOLE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 1020 | 25075739 |
IT |
82 | 1 |
Pneumonia, Influenza, Pyrexia, |
||||
| 1021 | 25075802 |
US |
||
Pneumonia, Lung disorder, Therapeutic response shortened, |
||||
MEPOLIZUMAB, |
||||
| 1022 | 25075827 |
US |
75 | 2 |
Pneumonia, Urinary tract infection, |
||||
AVAPRITINIB, |
||||
| 1023 | 25075883 |
JP |
74 | |
Nephrotic syndrome, Pneumonia, Decreased appetite, Cardiac failure, Oedema, Blood glucose increased, Treatment noncompliance, |
||||
DAPAGLIFLOZIN, DAPAGLIFLOZIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, NIFEDIPINE, NIFEDIPINE, FUROSEMIDE, FUROSEMIDE, TOLVAPTAN, TOLVAPTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, LANSOPRAZOLE, LANSOPRAZOLE, ZINC ACETATE, SODIUM ZIRCONIUM CYCLOSILICATE, |
||||
| 1024 | 25075997 |
CA |
78 | 2 |
Febrile neutropenia, Transfusion, Pneumonia, Chills, Neutrophil count abnormal, Pyrexia, |
||||
CEDAZURIDINE AND DECITABINE, DICLOFENAC, DICLOFENAC SODIUM, DOCUSATE CALCIUM, STOOL SOFTENER, FUROSEMIDE, LEVOTHYROXINE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MOMETASONE FUROATE, MOMETASONE, |
||||
| 1025 | 25076001 |
US |
||
Pneumonia, Symptom recurrence, Product dose omission issue, |
||||
MEPOLIZUMAB, |
||||
| 1026 | 25076006 |
US |
2 | |
Pneumonia, Abdominal pain upper, Feeling hot, Product use in unapproved indication, |
||||
| 1027 | 25076133 |
US |
65 | 1 |
Pulmonary oedema, Chest discomfort, Respiratory disorder, Dyspnoea, Chronic obstructive pulmonary disease, Pneumonia, |
||||
RISANKIZUMAB-RZAA, MONTELUKAST, PREDNISONE, SEMAGLUTIDE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LOSARTAN, METOPROLOL TARTRATE, METOPROLOL, FUROSEMIDE, APIXABAN, ROSUVASTATIN, PREGABALIN, |
||||
| 1028 | 25076158 |
AE |
70 | 2 |
Cardiac arrest, Pneumonia, |
||||
SACUBITRIL AND VALSARTAN, |
||||
| 1029 | 25076273 |
FR |
75 | 1 |
Lymphopenia, Benign prostatic hyperplasia, Thrombocytopenia, Neutropenia, Pneumonia, Escherichia bacteraemia, Clostridium colitis, Anaemia, Ear pain, Depression, Epistaxis, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, ISATUXIMAB, CARFILZOMIB, CARFILZOMIB, CARFILZOMIB, CARFILZOMIB, CARFILZOMIB, LANSOPRAZOLE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, FAMOTIDINE, CYANOCOBALAMIN, CYANOCOBALAMIN, FILGRASTIM, APIXABAN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, OXACILLIN SODIUM, OXACILLIN SODIUM, FOLIC ACID, |
||||
| 1030 | 25076314 |
AT |
||
Off label use, Metastases to central nervous system, Pneumonia, Metastases to lymph nodes, |
||||
OLAPARIB, DURVALUMAB, |
||||
| 1031 | 25076463 |
CA |
34 | 2 |
Nasal oedema, Oedema, Drug hypersensitivity, Asthma, Pneumonia, Chest pain, Malaise, Pain, Vomiting, |
||||
AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CALCIUM, CLONAZEPAM, ERGOCALCIFEROL, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RITUXIMAB, ROSUVASTATIN, THEOPHYLLINE, TRAMADOL HYDROCHLORIDE, CEFADROXIL, NEOMYCIN OINTMENT, POLYMYXIN B SULFATE, |
||||
| 1032 | 25076499 |
US |
2 | |
Pneumonia, Weight decreased, |
||||
ZILUCOPLAN, PYRIDOSTIGMINE BROMIDE ORAL, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TEMAZEPAM, GUAIFENESIN, ALBUTEROL SULFATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OLMESARTAN MEDOXOMIL, |
||||
| 1033 | 25076722 |
CA |
61 | 2 |
Illness, Pneumonia, Drug ineffective, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CIPROFLOXACIN HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, RAMIPRIL, LEVOTHYROXINE SODIUM, |
||||
| 1034 | 25076762 |
US |
2 | |
Pneumonia, |
||||
LENVATINIB, PEMBROLIZUMAB, CALCIUM, HYDROCHLOROTHIAZIDE, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, LISINOPRIL, |
||||
| 1035 | 25076768 |
JP |
73 | 2 |
Pneumonia, |
||||
GOLIMUMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 1036 | 25076812 |
US |
66 | 2 |
Pneumonia, |
||||
LENALIDOMIDE, |
||||
| 1037 | 25076840 |
US |
||
Pneumonia, Muscle spasms, |
||||
RAVULIZUMAB, |
||||
| 1038 | 25076845 |
CN |
2 | 1 |
Pulmonary hypertension, Disease recurrence, Pneumonia, Hypoxia, Condition aggravated, Methaemoglobinaemia, Product use issue, |
||||
NITRIC OXIDE, NITRIC OXIDE, |
||||
| 1039 | 25076852 |
CH |
81 | 1 |
Death, On and off phenomenon, Dementia, Dyskinesia, Fall, Syncope, Disorientation, Herpes zoster, Pneumonia, Meningitis, Renal failure, Blister, |
||||
| 1040 | 25078310 |
75 | 2 | |
Pneumonia, |
||||
ADALIMUMAB, |
||||
| 1041 | 25078340 |
38 | 2 | |
Productive cough, Dyspnoea, Pneumonia, |
||||
MACITENTAN, TADALAFIL, |
||||
| 1042 | 25078413 |
38 | 2 | |
Productive cough, Dyspnoea, Pneumonia, |
||||
TADALAFIL, MACITENTAN, |
||||
| 1043 | 25066155 |
US |
55 | 2 |
Pneumonia, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 1044 | 25066172 |
US |
1 | |
Pneumonia, Influenza, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1045 | 25066197 |
JP |
71 | 2 |
Cytopenia, Rash, Pyrexia, Pneumonia, Spinal compression fracture, Back pain, Constipation, Decreased appetite, |
||||
AZACITIDINE, (DAUNORUBICIN AND CYTARABINE) LIPOSOME, CYTARABINE, CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE, VENETOCLAX, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE, AMLODIPINE BESYLATE, URSODIOL, URSOSIOL, |
||||
| 1046 | 25066220 |
CA |
52 | 2 |
Pneumonia, COVID-19, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 1047 | 25066302 |
US |
23 | 1 |
Pneumonia, Pyrexia, Cough, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, SECUKINUMAB, |
||||
| 1048 | 25066318 |
US |
2 | |
Pulmonary hypertension, Nausea, Interstitial lung disease, Vomiting, Pneumonia, Hypotension, Blood potassium decreased, Throat irritation, Pain in jaw, Defaecation urgency, Productive cough, Haemorrhoidal haemorrhage, Headache, Cough, Feeling abnormal, Therapy non-responder, Weight increased, Rhinorrhoea, Dyspnoea, Dry throat, Blood iron decreased, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ERGOCALCIFEROL, ESCITALOPRAM OXALATE, ESCITALOPRAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PRAVASTATIN SODIUM, BUSPIRONE HYDROCHLORIDE, GABAPENTIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, AMLODIPINE BESYLATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 1049 | 25066404 |
IT |
84 | 1 |
Duodenitis, Pneumonia, Neutropenia, Brain injury, Gingival bleeding, Gingival bleeding, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, AZACITIDINE, AZACITIDINE FOR, ALLOPURINOL, FILGRASTIM, FILGRASTIM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 1050 | 25066522 |
CA |
75 | 2 |
Pneumonia, |
||||
ZOLEDRONIC ACID, |
||||
| 1051 | 25066678 |
CA |
2 | |
Pneumonia, Arthritis, Ear infection, Illness, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CYCLOBENZAPRINE, GABAPENTIN, DULOXETINE HYDROCHLORIDE, PREDNISONE, |
||||
| 1052 | 25066689 |
US |
58 | 2 |
Pneumonia, |
||||
FUROSEMIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ALBUTEROL SULFATE, CROMOLYN SODIUM, AMBRISENTAN, IRON, TADALAFIL, SPIRONOLACTONE, |
||||
| 1053 | 25066758 |
US |
1 | |
Pneumonia, Product dose omission issue, |
||||
ENSIFENTRINE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MONTELUKAST, PREDNISONE, NINTEDANIB, |
||||
| 1054 | 25066778 |
CA |
47 | 2 |
Blood pressure increased, Bronchitis, Cough, Pneumonia, Product dose omission issue, Pruritus, Stress, Urticaria, Vertigo, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, MONTELUKAST, RANITIDINE, |
||||
| 1055 | 25066801 |
CA |
||
Bursitis, Fall, Finger deformity, Folliculitis, Gastrooesophageal reflux disease, Hepatitis, Hypoaesthesia, Inflammation, Injury, Liver function test increased, Mobility decreased, Muscular weakness, Neck pain, Pain in extremity, Pneumonia, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ERENUMAB-AOOE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 1056 | 25066886 |
DE |
72 | 2 |
Pneumonia, |
||||
LETROZOLE, LETROZOLE TABLETS, PALBOCICLIB, PALBOCICLIB, |
||||
| 1057 | 25066898 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
RITUXIMAB, CLONAZEPAM, OMALIZUMAB, OMALIZUMAB, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, |
||||
| 1058 | 25066942 |
US |
33 | 2 |
Pneumonia, Tachycardia, Hypoxia, Hidradenitis, Urinary tract infection, Oral candidiasis, Fungal infection, Cough, |
||||
BIMEKIZUMAB, |
||||
| 1059 | 25066973 |
BR |
87 | 1 |
Pneumonia, Lung disorder, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, |
||||
| 1060 | 25067136 |
NL |
78 | 1 |
Pneumonia, Tremor, Choking, Therapeutic product effect variable, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 1061 | 25067151 |
CN |
42 | 1 |
Myelosuppression, Pneumonia, Diarrhoea, |
||||
PRALSETINIB, PRALSETINIB, |
||||
| 1062 | 25067152 |
US |
||
Pneumonia, Nasopharyngitis, Multiple allergies, Seasonal allergy, Bronchitis, |
||||
BENRALIZUMAB, |
||||
| 1063 | 25067232 |
JP |
81 | 1 |
Pneumonia, Fall, Malnutrition, Product prescribing issue, |
||||
ENZALUTAMIDE, |
||||
| 1064 | 25067309 |
US |
83 | 2 |
Influenza, Intentional product misuse, Pneumonia, |
||||
PACRITINIB, |
||||
| 1065 | 25067320 |
CA |
||
Asthma, Pneumonia, Candida infection, Cough, Dysphonia, |
||||
MEPOLIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, |
||||
| 1066 | 25067466 |
AU |
1 | |
Pneumonia, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 1067 | 25067469 |
CA |
1 | |
Pneumonia, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 1068 | 25067623 |
US |
72 | 2 |
Pneumonia, Chronic obstructive pulmonary disease, |
||||
CLOZAPINE, |
||||
| 1069 | 25067745 |
JP |
7 | |
Pneumonia, |
||||
PEMBROLIZUMAB, CARBOPLATIN, CISPLATIN, |
||||
| 1070 | 25067779 |
CA |
43 | 2 |
Pulmonary fibrosis, Retinitis, Rheumatic fever, Exposure during pregnancy, Injury, Joint range of motion decreased, Infusion related reaction, Joint stiffness, Joint swelling, Joint dislocation, Intentional product use issue, Irritable bowel syndrome, Laryngitis, Live birth, Liver function test increased, Liver injury, Lower limb fracture, Lupus-like syndrome, Lupus vulgaris, Maternal exposure during pregnancy, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Oedema peripheral, Off label use, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Prescribed overdose, Prescribed underdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriasis, Psoriatic arthropathy, Pyrexia, Rash, Red blood cell sedimentation rate increased, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE, OXYCODONE, OXYCODONE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 1071 | 25068044 |
CA |
30 | 2 |
Pneumonia, Influenza, Ear infection, |
||||
INFLIXIMAB, |
||||
| 1072 | 25068266 |
US |
2 | |
Pneumonia, Sepsis, Melaena, Heart rate increased, |
||||
AMBRISENTAN, SILDENAFIL CITRATE, APIXABAN, |
||||
| 1073 | 25068629 |
DE |
82 | 1 |
Cardiac failure chronic, Vomiting, Fall, Pneumonia, |
||||
TAFAMIDIS MEGLUMINE, |
||||
| 1074 | 25068636 |
FR |
71 | 1 |
Confusional state, Pneumonia, Bicytopenia, |
||||
CARBOPLATIN, FLUOROURACIL, PEMBROLIZUMAB, |
||||
| 1075 | 25068735 |
US |
59 | 2 |
Pneumonia, |
||||
DUPILUMAB, |
||||
| 1076 | 25068772 |
US |
58 | 1 |
Pneumonia, Therapeutic response unexpected, |
||||
DUPILUMAB, DUPILUMAB, OMALIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALBUTEROL SULFATE, DULOXETINE HYDROCHLORIDE, |
||||
| 1077 | 25068828 |
US |
56 | 2 |
Pneumonia, |
||||
DUPILUMAB, |
||||
| 1078 | 25068914 |
CA |
44 | 1 |
Blood pressure increased, Bronchitis, Pneumonia, Productive cough, Respiratory tract congestion, Sinus pain, Tinnitus, Upper-airway cough syndrome, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CALCIUM, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, MAGNESIUM, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, ESOMEPRAZOLE MAGNESIUM, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, VITAMIN C, ERGOCALCIFEROL, |
||||
| 1079 | 25069002 |
US |
43 | 1 |
Pneumonia, |
||||
BELUMOSUDIL, |
||||
| 1080 | 25069081 |
US |
60 | 1 |
Pneumonia, Upper respiratory tract infection, |
||||
DUPILUMAB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, PREDNISONE, AMLODIPINE BESYLATE, TORSEMIDE, BUDESONIDE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ROSUVASTATIN, MONTELUKAST SODIUM, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TORSEMIDE, TREPROSTINIL, CETIRIZINE HCL, CETIRIZINE, IPRATROPIUM BROMIDE AND ALBUTEROL, POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES, |
||||
| 1081 | 25069252 |
US |
||
Pneumonia, Influenza, |
||||
CAPIVASERTIB, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, CYCLOBENZAPRINE, APIXABAN, FERROUS SULFATE, FULVESTRANT, GABAPENTIN, METOPROLOL TARTRATE, METOPROLOL, VITAMIN C, |
||||
| 1082 | 25069335 |
CA |
34 | 2 |
Pneumonia, |
||||
GOLIMUMAB, |
||||
| 1083 | 25069386 |
US |
||
Respiratory failure, Septic shock, Pneumonia, Renal transplant failure, Adenovirus infection, Acute kidney injury, |
||||
PREDNISONE, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 1084 | 25069740 |
US |
59 | 1 |
Pneumonia, Staphylococcal infection, Mobility decreased, Fatigue, Illness, Dyspnoea, Cough, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, LISINOPRIL, |
||||
| 1085 | 25069834 |
US |
42 | 2 |
Pneumonia, Bronchitis, Therapeutic response decreased, Incorrect dose administered, |
||||
DUPILUMAB, MONTELUKAST SODIUM, CETIRIZINE HYDROCHLORIDE, |
||||
| 1086 | 25069861 |
CA |
55 | 2 |
Aphonia, Bronchitis, Bronchospasm, COVID-19, Drug hypersensitivity, Illness, Occupational exposure to dust, Perfume sensitivity, Pneumonia, Sensitivity to weather change, Throat clearing, Upper respiratory tract infection, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUDESONIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, |
||||
| 1087 | 25070017 |
US |
||
Pneumonia, |
||||
ELACESTRANT, ELACESTRANT, |
||||
| 1088 | 25070018 |
ZA |
2 | |
Upper gastrointestinal haemorrhage, Treatment failure, Pneumonia, |
||||
ADALIMUMAB, AZATHIOPRINE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 1089 | 25070066 |
CN |
37 | 2 |
Pneumonia, Immunodeficiency, Anaemia, Decreased appetite, Hyperlipidaemia, Sleep disorder, |
||||
BEVACIZUMAB, BEVACIZUMAB, |
||||
| 1090 | 25070127 |
CA |
||
Chronic obstructive pulmonary disease, Insomnia, Anxiety, Arthralgia, Pneumonia, Pulmonary fibrosis, Inappropriate schedule of product administration, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 1091 | 25070144 |
US |
||
Pneumonia, Seizure, Illness, |
||||
GANAXOLONE, |
||||
| 1092 | 25070185 |
1 | ||
Influenza, Pneumonia, Headache, Irritable bowel syndrome, Dyspnoea exertional, |
||||
MACITENTAN, RIOCIGUAT, |
||||
| 1093 | 25070193 |
PT |
1 | |
Pneumonia, Septic shock, |
||||
ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, PANTOPRAZOLE, INSULIN GLARGINE, NIFEDIPINE, ENALAPRIL, CARVEDILOL, DAPAGLIFLOZIN, ASPIRIN, CITRIC ACID, SODIUM BICARBONATE EFFERVESCENT TABLET, BUFFERED ASPIRIN, ERYTHROPOIETIN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, |
||||
| 1094 | 25070207 |
ES |
74 | 2 |
Febrile neutropenia, Pneumonia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, PREDNISONE, |
||||
| 1095 | 25070296 |
CA |
35 | 2 |
Pneumonia, Off label use, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, IRON, HYDROMORPHONE HYDROCHLORIDE, |
||||
| 1096 | 25070382 |
US |
2 | |
Viral infection, Pneumonia, |
||||
PANCRELIPASE, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, DORNASE ALFA, IVACAFTOR, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 1097 | 25070398 |
CA |
40 | 2 |
Pneumonia, Lower respiratory tract infection, Helicobacter infection, Wound infection, Nasopharyngitis, Onychomycosis, Taste disorder, Live birth, Normal newborn, Exposure during pregnancy, Off label use, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, APREMILAST, CANDESARTAN, CANDESARTAN, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, OXYCODONE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, RAMIPRIL, RAMIPRIL, RAMIPRIL, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CALCIUM, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, BUPRENORPHINE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, GOLD, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ERGOCALCIFEROL, ERGOCALCIFEROL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, MINOCYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, NICOTINAMIDE, MEPOLIZUMAB, MEPOLIZUMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RANITIDINE, TRAMADOL HYDROCHLORIDE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, VITAMIN C, NAPROXEN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TETRACYCLINE HYDROCHLORIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, |
||||
| 1098 | 25070723 |
CA |
53 | 2 |
Pneumonia, Infusion site oedema, Infusion site erythema, Infusion site swelling, Infusion site pain, Wrong technique in product usage process, Fatigue, |
||||
| 1099 | 25070879 |
US |
61 | 1 |
Pneumonia, Influenza, Productive cough, Chest discomfort, Decreased appetite, |
||||
DUPILUMAB, |
||||
| 1100 | 25070955 |
CA |
43 | 2 |
Oedema peripheral, Intentional product use issue, Off label use, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Prescribed overdose, Prescribed underdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatic fever, |
||||
ERENUMAB-AOOE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OXYCODONE, OXYCODONE, OXYCODONE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28